Biopharma, Biotechnology, Life Science, Medical, Pharmaceutical
Ratio Therapeutics
Ratio Therapeutics is a clinical-phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.
Series C · $70M · 67d agoratiotx.com
Hiring velocity
- Open roles
- 7
- Added, 30 days
- +0
- Added, 7 days
- +0
- Closed, 30 days
- 0
- Raised
- 67 days ago
- Led by
- Eli Lilly, Catalio Capital Management, Bristol-Myers Squibb, Cornell University, Duquesne Family Office
- Team size
- 11-50
- HQ
- Boston, Massachusetts, United States
- Tracked since
- Oct 4, 2026
Where they're hiring
Science2
Hardware2
Engineering2
Open roles at Ratio Therapeutics
+ 7 roles posted in the last 48 hours, visible to members →Source: ratiotx.com, checked daily.